BioCentury
ARTICLE | Company News

Ono Pharmaceutical, Santen deal

April 11, 2016 7:00 AM UTC

Ono granted Santen exclusive, worldwide rights to develop and commercialize ONO-9054. Ono will receive an undisclosed upfront payment and is eligible for milestone payments and royalties. ONO-9054, a...